Rockcliffe Labs
Rockcliffe Labs Inc. is a Canadian biotechnology venture creation platform that integrates academic research with clinical, regulatory, and commercialization expertise to bring therapies to market. The company develops a diversified pipeline of pharmaceuticals, diagnostics, and bio-based technologies by licensing breakthrough technologies from leading Canadian research institutions. Its lead program focuses on advancing a late-stage biomarker-based candidate for sepsis, aiming to address a significant unmet medical need in intensive care. Rockcliffe Labs holds exclusive rights in North America, with options for expansion into other global regions.
Leadership & Board
Latest Estimated Valuation
- Estimated Valuation
- $300M
- Total Amount Raised
- $75M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $75M
- Latest Funding Round
- Investment
- Post-Money Valuation
- $300M
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Oct 08, 2025 | Investment | $75.00M | $300.00M |
Investors
| Investor Name | Funding Round |
|---|---|
| Canadian University | Investment |
| New Canadian Investors | Investment |
Similar Companies
A snapshot of private companies similar to Rockcliffe Labs, helping you discover and navigate related company profiles.
